Clinical Proteomic Technologies for Cancer Initiative (CPTAC) Phase II
No involved investigator sites defined.
The objective of the "System Suitability (CompRef) Study" was to validate mass spectrometry protocols used at each Proteome Characterization Center (PCC).
There are currently no biomarkers annotated for this protocol.
No datasets are currently associated with this protocol.